"Natural" antibodies and histo-blood groups in biological development with respect to histo-blood group A. A perspective review

Immunobiology

Volumn 216, Issue 12, 2011, Pages 1318-1321

  Arend, Peter ^a,b  

^a Research Laboratories Chemie Grünenthal ^*  (Germany)

^b GRÜNENTHAL GMBH   (Germany)

Author keywords

"Natural" antibody; Embryonic stem cells; Neo expression; Parthenogenesis

Indexed keywords

AGGLUTININ; ANTIBODY; ANTIGEN; AUTOANTIBODY; BLOOD GROUP A ANTIBODY; BLOOD GROUP A ANTIGEN; BLOOD GROUP B ANTIGEN; EPITOPE; GALACTOSYL ANTIBODY; GALNAC ANTIBODY; GLYCOSPHINGOLIPID; GLYCOSYLTRANSFERASE; GLYCOSYLTRANSFERASE 6; GLYCOTRANSFERASE; HEMOLYSIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; N ACETYLGALACTOSAMINE; NATURAL ANTIBODY; TRANSFERASE; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ANTIGEN EXPRESSION; BIOLOGICAL ACTIVITY; BLOOD GROUP; BLOOD GROUP A; BLOOD GROUP A GENE; BLOOD GROUP AB GENE; BLOOD GROUP B GENE; CROSS REACTION; DEVELOPMENT; EMBRYONIC STEM CELL; ENZYME SYNTHESIS; GENE; GENETIC POLYMORPHISM; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PARTHENOGENESIS; PHYLOGENY; PRIORITY JOURNAL; REVIEW; SERUM;

EID: 80054930058     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2011.04.008     Document Type: Review

References (47)

1. Arend P. Observations on different origins of "naturally" occurring antibodies. European Journal of Immunology 1971, 5:398-402.
2. Arend P., Nijssen J. Significance of specific ovarian receptors for syngeneic naturally-occurring haemagglutinating anti-A antibodies. Journal of Immunogenetics 1976, 3:373-382.
3. Arend P., Nijssen J. Age-dependent appearance of A-specific ovarian glycolipids and syngeneic "natural" anti-A hemolysin in mice. Zeitschrift fur Immunitatsforschung. Immunobiology 1977, 153:74-84.
4. Arend P., Nijssen J. A-specific autoantigenic ovarian glycolipids inducing production of "natural" anti-A antibody. Nature 1977, 269:255-257.
5. Arend P. An auto-reactive A-like ovarian determinant distinct from xeno-reactive A-like structures. Immunobiology 1979, 156:410-417.
6. Baumgarth Nicole, et al. Inherent specificities in natural antibodies, a key to immune defense against pathogen invasion. Springer Seminars in Immunopathology 2005, 26:347-362.
7. Bloom S., et al. Inappropriate expression of blood group antigens on biliary and colonic epithelia in primary sclerosing cholangitis. Gut 1993, 34:977-983.
8. Casali P., Schettino E. Structure and function of natural antibodies. Current Topics in Microbiology and Immunology 1996, 210:167-179.
9. Cheng H., Chamley L. Cryptic natural autoantibodies and co-potentiators. Autoimmunity Reviews 2008, 7:431-434.
10. Clausen H., et al. Incompatible A antigen expressed in tumors of blood group O individuals: immunochemical, immunohistologic and enzymatic characterization. The Journal of Immunology 1986, 136:326-330.
11. David Leonor, et al. Biosynthetic basis of incompatible histo-blood group A antigen expression: anti-A transferase antibodies reactive with gastric cancer tissue of type O individuals. Cancer Research 1993, 53:494-5500.
12. Downs S.M. Stimulation of parthenogenesis in mouse ovarian follicles by inhibitors of inosine monophosphate dehydrogenase. Biology of Reproduction 1990, 43:426-437.
13. Duk M., et al. Specificity of human anti-NOR antibodies, a distinct species of "natural" anti-galactosyl antibodies. Glycobiology 2003, 13:279-284.
14. Eisler M. über ein gemeinsames Antigen in den Zellen des Menschen und in Shiga-Bazillen. Zeitschrift fur Immunitatsforschung. Immunobiology 1930, 67:38-49.
15. Gates M.A., et al. ABO blood group and incidence of epithelial ovarian cancer. International Journal of Cancer 2011, 128(2):482-486.
16. Galili U., et al. A unique natural human IgG antibody with anti-α-galactosyl specificity. Journal of Experimental Medicine 1984, 160:1519-2153.
17. Gonzalez R., et al. Specificity of natural serum antibodies present in phylogenetically distinct fish species. Immunology 1988, 63:31-36.
18. Hakomori S. Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. Cancer Research 1985, 45:2405-2414.
19. Hakomori S. Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer. Biochimica et Biophysica Acta 1999, 1473:247-266.
20. Hirota M., et al. Purification and analysis of glycoproteins bearing blood group-A determinants from hamster pancreatic ductal adenocarcinomas. Cancerogenesis 1992, 13:1829-1833.
21. Hirota M., et al. Modification of blood group A antigen expression in a pancreatic cancer cell line (PC-1) by inhibitors of N-glycan processing. Journal of Cellular Biochemistry 1992, 13-20.
22. Holt P.D.J., Anstee D.J. A natural Anti-A agglutinin in the serum of the brown trout (Salmo trutta). Vox Sanguinis 1975, 29:286-291.
23. Isaev D.A., et al. Different influences of genomic imprinting on the development of parthenogenetic cell clones in C57BL/6 and CBA mice. Russian Journal of Developmental Biology 2001, 32:292-297.
24. Iwamato S., et al. Rat encodes the paralogous gene equivalent of the human histo-blood group ABO gene, association with antigen expression by overexpression of human ABO transferase. Journal of Biological Chemistry 2002, 277:46463-46469.
25. Jagadeesh B., et al. Natural antibodies sustain differentiation and maturation of human dendritic cells. PNAS 2004, 101:14210-14215.
26. Kim K., et al. Recombination signatures distinguish embryonic stem cells derived by parthenogenesis and somatic cell nuclear transfer. Cell Stem Cell 2007, 1:346-352.
27. Kyoko H., et al. Positive selection of natural autoreactive B cells. Science 1999, 285:113-116.
28. Landsteiner K. Individual differences in human blood. Science 1931, 73:403-409.
29. Lee J.S., et al. Expression of blood-group antigen A - a favorable prognostic factor in non-small-cell lung cancer. New England Journal of Medicine 1991, 324:1084-1090.
30. Lo-Man R., et al. Anti-tumor immunity provided by a synthetic multiple antigenic glycopeptide displaying a Tri-Tn glycotope. The Journal of Immunology 2001, 166:2849-2854.
31. Marchalonis J., et al. Evolutionary factors in the emergence of the combinatorial germline antibody repertoire. Advances in Experimental Medicine and Biology 2001, 484:13-30.
32. Metoki R., et al. Deletion of histo-blood group A and B antigens and expression of incompatible A antigen in ovarian cancer. Journal of the National Cancer Institute 1989, 15:1151-1157.
33. Nash R., et al. The lectin Dolichos biflorus agglutinin recognizes glycan epitopes on the surface of murine embryonic stem cells: a new tool for characterizing pluripotent cells and early differentiation. Stem Cells 2007, 4:974-982.
34. Néron S., Lemieu R. Type 2 T-cell-independent murine immune response to the human AB0 blood group antigens. Vox Sanguinis 1994, 67:68-74.
35. Okada Y., et al. Neoexpression of ABH and Lewis blood group antigens in human hepatocellular carcinomas. Journal of the National Cancer Institute 1987, 1:19-28.
36. Polak de Fried E., et al. Human parthenogenetic blastocysts derived from noninseminated cryopreserved human oocytes. Fertility and Sterility 2008, 89:943-947.
37. Rocher J. Dévelopement de modèles expérimentaux envue de la mise au point de protocoles d'immunothérapie ciblant les antigènes glycanniques sialyl-Tn et A type 3/4, antigènes associés aux carcinomes 2005, Ecole Pratique des Hautes Etudes (Sciences de la Vie et de la Terre), Diplomé.
38. Spalter S.H., et al. Normal human serum contains natural antibodies reactive with autologous ABO blood group antigens. Blood 1999, 93:4418-4424.
39. Springer G.F., et al. Blood group activity of gram negative bacteria. Journal of Experimental Medicine 1961, 113:1077-1093.
40. Springer G.F., Horton R.E. Blood group isoantibody stimulation in man by feeding blood group-active bacteria. Journal of Clinical Investigation 1969, 48:1280-1291.
41. Stevens L.C., et al. Viable chimaeras produced from normal and parthenogenetic mouse embryos. Nature 1977, 269:515-517.
42. Turcot A.L., et al. Cloning of a rat gene encoding the histo-blood group B enzyme: rats have more than one Abo gene. Glycobiology 2003, 12:919-928.
43. Turcot-Dubois A.L., et al. Long-term evolution of the CAZY glycosyltransferase 6 (ABO) gene family from fishes to mammals, a birth-and-death evolution model. Glycobiology 2007, 17:516-528.
44. Uhlenbruck G., et al. Blood group like substances in some marine invertebrates. Different forms of the blood group A-like substances: glycoprotein and polysaccharide type. Comparative Biochemistry and Physiology. Part B: Biochemistry and Molecular Biology 1975, 50:369-372.
45. Uyenoyama M. On the evolution of parthenogenesis. II. Inbreeding and the cost of meiosis. Evolution 1985, 39:1194-1206.
46. Wang H., Chow D.A. Natural antibody-induced intracellular signalling and growth control in C3H 10T1/2 fibroblast variants. Immunology 2000, 4:458-466.
47. Yamamoto M., et al. Murine equivalent of the human histo-blood group ABO gene is a cis-AB gene and encodes a glycosyltransferase with both A and B transferase activity. Journal of Biological Chemistry 2001, 276:13701-13708.